Accountability for informed consent assurance in medicines and vaccination programmes

SPENCER JONES made this Official Information request to Ministry of Health

Currently waiting for a response from Ministry of Health, they must respond promptly and normally no later than (details and exceptions).

From: SPENCER JONES

Dear Ministry of Health,
Agency

Ministry of Health (lead)
With expected consultation or transfer to:
• Medsafe
• Health New Zealand – Te Whatu Ora

Timeframe

1 January 2019 – present

Official Information Act request

I am seeking information about institutional accountability for informed consent assurance in relation to medicines and vaccination programmes in New Zealand.

This request does not seek copies of consent forms, training materials, or ethics standards, and does not repeat requests for documents previously confirmed as not held. It seeks clarity on responsibility, ownership, and assurance, rather than documentation.

Please provide information identifying:

1. Which agency (or agencies) is formally responsible for assuring that informed consent requirements are met in the context of:
• medicines approval and regulation;
• vaccination and immunisation programmes; and
• large-scale or population-level use of medicines.
2. Whether that responsibility is defined in legislation, Cabinet decisions, inter-agency agreements, delegations, or operating models, and if so:
• the instrument relied upon (e.g. Act, regulation, Cabinet paper, mandate, or formal role description);
• the agency or role designated as accountable.
3. Whether any agency has responsibility for reviewing or assuring consent adequacy at a system level, including:
• monitoring whether consent practices meet legal and ethical requirements;
• identifying systemic risks or gaps in consent practice; or
• initiating corrective action where consent is found to be inadequate.
4. If no single agency holds this responsibility, please confirm:
• whether accountability is considered distributed;
• how risks arising from that fragmentation are identified or managed; and
• whether the absence of a single accountable body has been formally considered.
5. Whether any agency has considered establishing a formal consent-assurance or consent-governance function, and if so:
• when this was considered;
• which agency led or participated in that consideration; and
• the outcome (including reasons for proceeding or not proceeding).

Clarifications
• This request is about responsibility and accountability, not about producing policies, manuals, or training content.
• If the information requested is held across multiple agencies, please transfer or consult as appropriate under sections 14 and 15 of the OIA.
• If the information is not held, please specify which agency was expected to hold it, and on what basis.

Public interest

There is a strong public interest in understanding who is accountable for ensuring that informed consent — a core legal and ethical requirement — is coherently assured across medicines regulation, ethics oversight, and health service delivery.

Kind regards,

Spencer Jones

Link to this

SPENCER JONES left an annotation ()

Public annotation — Why this follow-up OIA exists

This request follows a sequence of Official Information Act responses that have established an important but under-examined fact: no New Zealand public agency has clearly articulated responsibility for assuring informed consent across medicines regulation, ethics oversight, and health service delivery.

Earlier requests confirmed what information does not exist.

This follow-up request tests who, if anyone, is accountable.



What has already been established on the public record

1. Medicines Act & consent (FYI #33349)

In response to FYI #33349 — Medicines Act interpretation, ethics oversight, and consent frameworks, the Ministry of Health / Medsafe and Health New Zealand confirmed that:
• The Medicines Act 1981 regulates medicines, but does not address informed consent.
• Medsafe holds no internal analysis or guidance explaining how medicines approval interacts with consent obligations.
• Ethics oversight relies on generic national standards, with no vaccine-specific consent framework.
• Health NZ relies on training and guidance only, with no national consent templates, audits, or assurance reviews.
• No agency has conducted a system-level evaluation of whether consent practices meet legal or ethical thresholds.

That request is now closed and marked on the public record as “information not held” in respect of core governance artefacts.



2. A confirmed governance gap

Taken together, those responses establish that:
• Medicines regulation, ethics oversight, and clinical practice are institutionally siloed.
• No agency holds documents that bridge these domains.
• The absence of material is not accidental — agencies explicitly state such information is not held.

The unanswered question is therefore no longer “what documents exist?”, but:

Who is responsible for assuring informed consent, if anyone?



Purpose of this follow-up request

This follow-up OIA is deliberately framed to avoid re-litigating document existence.

It instead asks agencies to identify:
• which agency (or agencies) is formally responsible for consent assurance;
• whether that responsibility is defined in law, Cabinet decisions, or operating models;
• whether any agency reviews consent adequacy at a system level;
• how risks arising from fragmented responsibility are identified or managed; and
• whether the absence of a single accountable body has ever been considered.

In short, this request tests accountability and ownership, not paperwork.



Why this matters

For the public, this goes to a basic expectation:
that informed consent — a core legal and ethical requirement — is not left to chance or informal practice.

For journalists and investigators, the significance is structural:
• If no agency is accountable, that is a governance finding, not an administrative oversight.
• If accountability is distributed, the public is entitled to know how risks are managed.
• If no one is responsible, that itself is high-value public-interest information.

This request is designed so that any answer — including “no agency is responsible” — is meaningful.



Related requests for context

Readers may wish to review the following related FYI requests, which together form a coherent public record:
• FYI #33349 — Medicines Act interpretation, ethics oversight, and consent frameworks
Established that no agency holds consent-governance artefacts.
• FYI #33398 — Veterans’ Advisory Board visibility of charities and signposting gaps
Demonstrates a similar pattern of acknowledged gaps without ownership.
• FYI #33682 — Decision-making on veteran navigation and non-statutory support
Tests accountability rather than document existence in a different policy domain.

These requests reflect a broader pattern: absence of ownership where responsibility spans multiple agencies.



What to watch for in the response

When this request is answered, key signals will include:
• whether agencies identify a lead accountable body, or deny that one exists;
• whether accountability is described as “shared” without defined assurance mechanisms;
• whether responsibility is implicitly pushed back onto clinicians or providers; or
• whether the question is reframed as operational rather than governance-level.

Each of those outcomes has distinct implications.



Status

This request is active.
No assumptions are made about the outcome.

This annotation is provided to assist readers in understanding why the question is being asked, and how it fits into the wider public record.

Link to this

Things to do with this request

Anyone:
Ministry of Health only: